Evidence map›Paper›PMID 20044459›Full record

ReviewThe European respiratory journal2010

Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.

R N van Zyl Smit, M Pai, W W Yew, C C Leung, A Zumla, E D Bateman, K Dheda

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in The European respiratory journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 116 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04070248 unknown statusnot on this mapstarted 2019, after this paper: background citation

Investigating the Association Between Altered Lung MicroBiome and HIV-associated Chronic Obstructive Pulmonary Disease in a Ugandan Cohort

TypeobservationalSponsorMakerere UniversityRan2019 to 2021Enrolled200ConditionsCOPD, HIV/AIDSArmsNo intervention
NCT05223114 completednot on this mapstarted 2022, after this paper: background citation

Airway Microbiome and Th17-mediated Inflammation in COPD Among HIV-infected Individuals in a Rural Ugandan Cohort

TypeobservationalSponsorMakerere UniversityRan2022 to 2023Enrolled160ConditionsCOPD, HIV Infections, Respiratory DiseaseArmsNot applicable (N/A)
3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 2 syntheses or guidelines pooled it, 297 citations in OpenAlex.

  1. Pooled it
  2. Corticosteroids for tuberculous pleurisy.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Predictors of TB disease in HIV-exposed children from Southern Africa.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Post-tuberculosis morbidities and their associated mortality: moving from challenges to solutions.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Household air pollution and risk of pulmonary tuberculosis in HIV-Infected adults.Environmental health : a global access science source · 2024
    Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 4 countries.

R N van Zyl SmitLung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Dept of Medicine, University of Cape Town, Cape Town, South Africa. rvzs@iafrica.com
M Pai
W W Yew
C C Leung
A Zumla
E D Bateman
K Dheda
University of Cape Town · ZAMcGill University · CA

Funding

Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
CIHRFIC NIH HHS R24 TW007988FIC NIH HHS R24TW007988
6 · The paper itself

Abstract

Tuberculosis (TB), smoking, HIV and chronic obstructive pulmonary disease (COPD) are burgeoning epidemics in developing countries. The link between TB and HIV is well established. Less well recognised is the strong relationship between tobacco smoking and the development and natural history of TB. These associations are of considerable relevance to public health and disease outcomes in individuals with TB. Moreover, tobacco smoking, a modifiable risk factor, is associated with poorer outcomes in HIV-associated opportunistic infections, of which TB is the commonest in developing countries. It is now also becoming clear that TB, like tobacco smoke, besides its known consequences of bronchiectasis and other pulmonary morbidity, is also a significant risk factor for the development of COPD. Thus, there is a deleterious and synergistic interaction between TB, HIV, tobacco smoking and COPD in a large proportion of the world's population. Further work, specifically mechanistic and epidemiological studies, is required to clarify the role of tobacco smoke on the progression of TB and HIV infection, and to assess the impact of smoking cessation interventions. These interactions deserve urgent attention and have major implications for coordinated public health planning and policy recommendations in the developing world.

Indexed as

Global HealthHIV InfectionsHumansPulmonary Disease, Chronic ObstructiveSmokingTuberculosis, Pulmonary

Identifiers

PMID20044459
PMCPMC5454527
OpenAlexW2128476072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.